Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BILL Holdings
BILL
|
+$41.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.9M |
| 3 |
Gotham Enhanced 500 ETF
GSPY
|
+$35.8M |
| 4 |
PayPal
PYPL
|
+$17.4M |
| 5 |
NATI
National Instruments Corp
NATI
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$14M |
| 2 |
Lam Research
LRCX
|
+$12.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$9.54M |
| 4 |
VMW
VMware, Inc
VMW
|
+$9.3M |
| 5 |
Valvoline
VVV
|
+$9.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.4% |
| 2 | Industrials | 12.68% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Healthcare | 8.73% |
| 5 | Financials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RWT
1301
Redwood Trust
RWT
$603M
| $91.9K | ﹤0.01% |
12,408
-3,749
| -23% | -$26.3K |
|
|
STKL
1302
DELISTED
SunOpta
STKL
| $84.4K | ﹤0.01% |
+15,428
| New | +$67.6K |
|
|
ORLA
1303
DELISTED
Orla Mining
ORLA
| $82.8K | ﹤0.01% |
+25,484
| New | +$80K |
|
|
SAND
1304
DELISTED
Sandstorm Gold
SAND
| $74.4K | ﹤0.01% |
+14,783
| New | +$70.5K |
|
|
VISN
1305
Vistance Networks Inc
VISN
$2.59B
| $70.3K | ﹤0.01% |
24,941
-5,386
| -18% | -$11.7K |
|
1306
Cipher Digital
CIFR
$6.55B
| $65.3K | ﹤0.01% |
15,811
+2,649
| +20% | +$8.07K |
|
1307
RUM Group Inc
RUM
$4.49B
| $54.3K | ﹤0.01% |
12,096
-3,451
| -22% | -$16.8K |
|
1308
ImmunityBio
IBRX
$8.26B
| $54.2K | ﹤0.01% |
+10,788
| New | +$33.9K |
|
1309
SmartRent
SMRT
$274M
| $53K | ﹤0.01% |
+16,612
| New | +$48.5K |
|
|
PGRE
1310
DELISTED
Paramount Group
PGRE
| $52.1K | ﹤0.01% |
10,083
-1,534
| -13% | -$7.28K |
|
1311
Virgin Galactic
SPCE
$467M
| $51.6K | ﹤0.01% |
+1,053
| New | +$41.6K |
|
|
SLI
1312
Standard Lithium
SLI
$612M
| $43.8K | ﹤0.01% |
21,702
-786
| -3% | -$1.96K |
|
1313
TeraWulf
WULF
$7.8B
| $43.1K | ﹤0.01% |
17,969
+6,593
| +58% | +$8.98K |
|
|
OPTU
1314
Optimum Communications Inc
OPTU
$323M
| $42.4K | ﹤0.01% |
+13,045
| New | +$34.2K |
|
1315
BigBear.ai
BBAI
$1.54B
| $40.8K | ﹤0.01% |
19,086
-5,282
| -22% | -$8.55K |
|
|
DHC
1316
Diversified Healthcare Trust
DHC
$1.94B
| $40.1K | ﹤0.01% |
+10,720
| New | +$25.2K |
|
1317
Cerus
CERS
$566M
| $35.5K | ﹤0.01% |
16,451
-2,355
| -13% | -$3.88K |
|
1318
IAMGOLD
IAG
$12.1B
| $29.2K | ﹤0.01% |
11,542
-41,117
| -78% | -$98.5K |
|
|
ASRT
1319
DELISTED
Assertio
ASRT
| $28.1K | ﹤0.01% |
1,752
-80
| -4% | -$1.98K |
|
1320
Emergent Biosolutions
EBS
$260M
| $25.9K | ﹤0.01% |
10,797
| – | – |
|
|
ACB
1321
Aurora Cannabis
ACB
$249M
| $15.6K | ﹤0.01% |
3,273
+510
| +18% | +$2.46K |
|
|
NVTA
1322
DELISTED
Invitae Corporation
NVTA
| $14.7K | ﹤0.01% |
23,403
+12,411
| +113% | +$7.42K |
|
|
GOEV
1323
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $11K | ﹤0.01% |
93
-16
| -15% | -$2.17K |
|
|
QVCGA
1324
DELISTED
QVC Group Inc Series A
QVCGA
| $9.22K | ﹤0.01% |
211
-826
| -80% | -$28.3K |
|
1325
Aaon
AAON
$6.55B
| – | – |
-6,904
| Closed | -$393K |
|
Similar funds
Joel Greenblatt's Q4 2023 Portfolio in Review
As of Q4 2023, Joel Greenblatt held 1,470 positions worth $5.39B, up 11% from $4.84B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Joel Greenblatt's Q4 2023 filing shows 157 new, 492 increased, 650 reduced and 145 closed positions. Its largest new stake was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M. The largest sale was Pfizer, an estimated $14M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Joel Greenblatt's largest Q4 2023 buy was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M.
- Joel Greenblatt added most to BILL Holdings in Q4 2023, an estimated $41.5M increase.
- Joel Greenblatt's biggest Q4 2023 reduction was Pfizer, cutting an estimated $14M.
- Joel Greenblatt fully exited VMware, Inc in Q4 2023, selling an estimated $9.3M.
- Joel Greenblatt's ten largest holdings make up 24% of its $5.39B portfolio in Q4 2023.
- Joel Greenblatt opened 157 new positions and closed 145 in Q4 2023.
- Joel Greenblatt's portfolio value rose 11% quarter-over-quarter to $5.39B.
Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.